Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Ilic, Branislav (56806538200)"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    ADA AS MAIN BIOCHEMICAL MARKER IN PATIENTS WITH TUBERCULOUS EFFUSION; [ADA KAO GLAVNI BIOHEMIJSKI MARKER KOD BOLESNIKA SA TUBERKULOZNIM IZLIVOM]
    (2023)
    Jankovic, Jelena (57211575577)
    ;
    Ilic, Branislav (56806538200)
    ;
    Djurdjevic, Natasa (57202011285)
    ;
    Jandric, Aleksandar (58485556800)
    Tuberculous pleuritis (TP) is one of the most common extra-pulmonary tuberculosis form. Because of tuberculous pleurisy is hard to diagnose due to slow course of disease and lack of specificity in symptoms and diagnostic methods. In that reason, we need multidisciplinary approach and efficient biomarkers. Acid-fast bacilli (AFB) staining, cultures and pathophysiological biopsy finding from the majority of patients are positive only in less than 10%. Löwenstein culture results need time about 6–8 weeks what delays diagnosis. Adenosine deaminase (ADA) is biomarker with high sensitivity and specificity (more than 90%) and considered as gold standard of biomarkers in the diagnosis of TP. It is very hard to distinguish malignant from TP with lymphocyte predomination, but in patient with malignant pleural effusion the level of ADA is decreased, opposite from TP. ADA in pleural punctate is a fast, simple, efficient and economical way for clarification the etiology of the pleural effusion as tuberculous pleurisy. Also, many studies have proved the role of ADA in the response to treatment for tuberculosis at follow up period. © 2023 Sciendo. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    ADA AS MAIN BIOCHEMICAL MARKER IN PATIENTS WITH TUBERCULOUS EFFUSION; [ADA KAO GLAVNI BIOHEMIJSKI MARKER KOD BOLESNIKA SA TUBERKULOZNIM IZLIVOM]
    (2023)
    Jankovic, Jelena (57211575577)
    ;
    Ilic, Branislav (56806538200)
    ;
    Djurdjevic, Natasa (57202011285)
    ;
    Jandric, Aleksandar (58485556800)
    Tuberculous pleuritis (TP) is one of the most common extra-pulmonary tuberculosis form. Because of tuberculous pleurisy is hard to diagnose due to slow course of disease and lack of specificity in symptoms and diagnostic methods. In that reason, we need multidisciplinary approach and efficient biomarkers. Acid-fast bacilli (AFB) staining, cultures and pathophysiological biopsy finding from the majority of patients are positive only in less than 10%. Löwenstein culture results need time about 6–8 weeks what delays diagnosis. Adenosine deaminase (ADA) is biomarker with high sensitivity and specificity (more than 90%) and considered as gold standard of biomarkers in the diagnosis of TP. It is very hard to distinguish malignant from TP with lymphocyte predomination, but in patient with malignant pleural effusion the level of ADA is decreased, opposite from TP. ADA in pleural punctate is a fast, simple, efficient and economical way for clarification the etiology of the pleural effusion as tuberculous pleurisy. Also, many studies have proved the role of ADA in the response to treatment for tuberculosis at follow up period. © 2023 Sciendo. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Bronchoscopy procedures in diagnostics and treatment of endobronchial tuberculosis
    (2025)
    Popevic, Spasoje (54420874900)
    ;
    Maric, Nikola (57219559898)
    ;
    Belic, Slobodan (57222640039)
    ;
    Karapandzic, Marija (59925574300)
    ;
    Janjic, Sanja Dimic (57208444020)
    ;
    Ilic, Branislav (56806538200)
    ;
    Trboljevac, Nikola (57722831100)
    ;
    Dubljanin, Drasko (57222039076)
    ;
    Stjepanovic, Mihailo (55052044500)
    Endobronchial tuberculosis is a rare form of tuberculosis that is characterized by the presence of tuberculous granuloma within the respiratory tract, usually in the trachea or main bronchi. Multiple key notes regarding this form make it difficult to detect and treat, which can lead to prolonged, lifelong even, problems that lead to a significant loss in quality of life. Even if the conventional treatment for tuberculosis is started on time, endobronchial tuberculosis can still develop. In those cases, a bronchoscopy should be performed to objectify the type of endobronchial tuberculosis and treat it in order to prevent permanent airway stenosis. In this paper, we will note the main characteristics of endobronchial tuberculosis, as well as bronchoscopy procedures used for its treatment such as balloon dilatation, laser, argon plasma coagulation, cryotherapy, and implementation of the stent. The main goal is to raise awareness of endobronchial tuberculosis to reduce the risk of complications of its mistreatment. Copyright © 2025 Popevic et al.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback